恶性外周神经鞘瘤(MPNST)演化的基因组模式与临床结局相关并可在游离DNA中检测
研究对95份恶性外周神经鞘瘤(MPNST)肿瘤样本进行全基因组和多区域外显子测序、转录组及甲基化分析,揭示肿瘤演化中基因组事件的顺序。PRC2基因失活和H3K27me3状态与不同演化途径相关,肿瘤样本和游离DNA(cfDNA)中检测到的特定体细胞拷贝数畸变(SCNA)可作为H3K27me3缺失和免疫浸润的替代标志并预测预后。
要点
- MPNST演化始于NF1双等位基因失活,随后CDKN2A或TP53丢失伴或不伴PRC2失活导致广泛SCNA。
- H3K27me3缺失肿瘤经广泛染色体丢失、全基因组加倍和8号染色体扩增演化,免疫细胞浸润较低。
- H3K27me3保留肿瘤呈广泛基因组不稳定但免疫细胞丰富表型;肿瘤和cfDNA中特定SCNA可预测预后。
核心结论
- MPNST肿瘤或cfDNA的体细胞拷贝数和甲基化谱可能作为早期诊断生物标志物,并将患者分层为预后和治疗相关亚组。
研究设计与样本
- 对95份MPNST肿瘤样本进行全基因组和多区域外显子测序、转录组和甲基化分析的研究。
主要发现
- NF1双等位基因失活后,CDKN2A或TP53丢失伴或不伴PRC2失活导致广泛体细胞拷贝数畸变(SCNA)。
- H3K27me3缺失肿瘤经广泛染色体丢失后发生全基因组加倍和8号染色体扩增,免疫细胞浸润水平较低。
- H3K27me3保留导致广泛基因组不稳定,但呈免疫细胞丰富表型。
- 肿瘤样本和游离DNA(cfDNA)中检测到的特定SCNA作为H3K27me3缺失和免疫浸润的替代标志,并预测预后。
关键数值与推荐
- PRC2基因失活和H3K27三甲基化(H3K27me3)状态与不同肿瘤演化途径相关。
- H3K27me3缺失肿瘤:广泛染色体丢失、全基因组加倍、8号染色体扩增、免疫细胞浸润较低。
- H3K27me3保留肿瘤:广泛基因组不稳定、免疫细胞丰富表型。
- 肿瘤样本和cfDNA中特定SCNA可替代H3K27me3缺失和免疫浸润并预测预后。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Malignant peripheral nerve sheath tumor (MPNST), an aggressive soft-tissue sarcoma, occurs in people with neurofibromatosis type 1 (NF1) and sporadically. Whole-genome and multiregional exome sequencing, transcriptomic, and methylation profiling of 95 tumor samples revealed the order of genomic events in tumor evolution. Following biallelic inactivation of NF1, loss of CDKN2A or TP53 with or without inactivation of polycomb repressive complex 2 (PRC2) leads to extensive somatic copy-number aberrations (SCNA). Distinct pathways of tumor evolution are associated with inactivation of PRC2 genes and H3K27 trimethylation (H3K27me3) status. Tumors with H3K27me3 loss evolve through extensive chromosomal losses followed by whole-genome doubling and chromosome 8 amplification, and show lower levels of immune cell infiltration. Retention of H3K27me3 leads to extensive genomic instability, but an immune cell-rich phenotype. Specific SCNAs detected in both tumor samples and cell-free DNA (cfDNA) act as a surrogate for H3K27me3 loss and immune infiltration, and predict prognosis. SIGNIFICANCE: MPNST is the most common cause of death and morbidity for individuals with NF1, a relatively common tumor predisposition syndrome. Our results suggest that somatic copy-number and methylation profiling of tumor or cfDNA could serve as a biomarker for early diagnosis and to stratify patients into prognostic and treatment-related subgroups. This article is highlighted in the In This Issue feature, p. 517.
引用
- Cortes-Ciriano I, Steele CD, Piculell K, et al. Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA. Cancer Discov. 2023. PMID: 36598417. doi:10.1158/2159-8290.CD-22-0786
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。